1-20 of 20
Jishi Wang, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Charactistics of Ph-Negative MPN Patients with Coexistence of JAK2V617F, Calr and MPL Mutation

Dan Ma, PhD, Ping Liu, Chengyun Pan, Bingqing Cheng, Yaming Zhang, Yan Wang, Xiuying Hu, Jishi Wang, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-142096
Published: 2020
Journal Articles

CD56 bri CD27 + CD11b +/- NK Cells Mediated Remission of Agvhd Via Immunoregulation

Ming Ni, MD, Peng Zhao, Qian Kang, Mei Zhao, Min Liu, Fengqi Zhang, Shisi Huang, Dan Ma, PhD, Yaming Zhang, Jiangyuan Zhao, Jishi Wang, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28.
https://doi.org/10.1182/blood-2020-141881
Published: 2020
Journal Articles

Inhibition of Heme Oxygenase-1 Attenuates Bortezomib Resistance in Multiple Myeloma Via Down-Regulating Gas6 Production

Zhaoyuan Zhang, Weili Wang, MD, Jie Xiong, PhD, Xingyi Kuang, PhD, Dan Ma, MD, Jishi Wang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1781.
https://doi.org/10.1182/blood-2019-130474
Published: 2019
Journal Articles

CD19-Directed Fast CART Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia: From Bench to Bedside

Cheng Zhang, Jiaping He, Li Liu, Jishi Wang, PhD, Sanbin Wang, Ligen Liu, Lei Gao, Li Gao, Yao Liu, Peiyan Kong, Jia Liu, Yu Han, Yongliang Zhang, Zhe Sun, Xun Ye, Yan He, Lianjun Shen, MD PhD, Wei Cao, Xi Zhang
Journal: Blood
Blood (2019) 134 (Supplement_1): 1340.
https://doi.org/10.1182/blood-2019-128006
Published: 2019
Journal Articles

Heme Oxygenase-1 in Leukemia Cells Promotes Cancer Associated Fibroblasts Mediating Progression of Acute Lymphoblastic Leukemia

Chengyun Pan, Dan Ma, MD, Qin Fang, Ping Liu, Jishi Wang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3958.
https://doi.org/10.1182/blood-2019-130440
Published: 2019
Journal Articles

HO-1 Promotes Resistance to EZH2 Inhibitor through the Prb-E2F Pathway: Corelated with the Conversion of Myelodysplastic Syndrome to Acute Myeloid Leukemia

Zhengchang He, Jishi Wang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5401.
https://doi.org/10.1182/blood-2019-131573
Published: 2019
Journal Articles

CUDC-101 Overcomes Arsenic Trioxide Resistance Via Caspase-Dependent PML-Rarα Degradation in Acute Promyelocytic Leukemia

Tianzhuo Zhang, Jishi Wang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5054.
https://doi.org/10.1182/blood-2019-131618
Published: 2019
Journal Articles

Elevated ANXA1 Expression Causes Glucocorticoid Resistance in Acute Lymphoblastic Leukemia Via Activating the Wnt/β-Catenin Signaling Pathway

Ping Liu, Dan Ma, MD, Jishi Wang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5198.
https://doi.org/10.1182/blood-2019-130322
Published: 2019
Journal Articles

LSD1 Inhibitor 4SC-202 Inducing Apoptosis in Myelodysplastic Syndrome Cells Via NF-κb-HO-1 Pathway

Weili Wang, MD, Zhaoyuan Zhang, Xingyi Kuang, PhD, Jishi Wang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5415.
https://doi.org/10.1182/blood-2019-130486
Published: 2019
Journal Articles

A Bcma and CD19 Bispecific CAR-T for Relapsed and Refractory Multiple Myeloma

Hua Zhang, Lei Gao, Li Liu, Jishi Wang, PhD, Sanbin Wang, Li Gao, Cheng Zhang, MD PhD, Yao Liu, Peiyan Kong, Jia Liu, Jiaping He, Yu Han, Hua Shi, Yan He, Xun Ye, Yi Zhao, Wei Cao, Lianjun Shen, Xi Zhang
Journal: Blood
Blood (2019) 134 (Supplement_1): 3147.
https://doi.org/10.1182/blood-2019-131056
Published: 2019
Journal Articles

Knockout Tumor Microenvironment HO-1 Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Acute Myeloid Leukemia

Zhen Zhou, Qin Fang, Dan Ma, MD, Danna Wei, Xiuying Hu, Yudan Liao, Jishi Wang, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2782.
https://doi.org/10.1182/blood-2018-99-117808
Published: 2018
Journal Articles

PIM Inhibitor SMI-4a Induces Cell Apoptosis and Cell Cycle Arrest in B-Cell Acute Lymphocytic Leukemia Cells Via the JAK2/STAT3 Pathway

Xingyi Kuang, Jie Xiong, Weili Wang, Xinyao Li, Tingting Lu, Jishi Wang, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4083.
https://doi.org/10.1182/blood-2018-99-117804
Published: 2018
Journal Articles

Regulation of HACE1 Expression Enhances HDAC Inhibitor Lmk-235-Mediated Apoptosis in Diffuse Large B-Cell Lymphoma Cells

Xinyao Li, Dan Ma, MD, Tingting Lu, Xingyi Kuang, Kunling Yu, Zhaoyuan Zhang, Weili Wang, Jishi Wang, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5299.
https://doi.org/10.1182/blood-2018-99-117842
Published: 2018
Journal Articles

Silencing HDAC3 Enhances Apoptosis of Acute B Lymphoblastic Leukemia Cells smurf2 Inducing By Inhibiting JAK/STAT3 Signal Pathway

Yongling Guo, Dan Ma, MD, Zhengchang He, Jie Xiong, Xingyi Kuang, Weili Wang, Kunling Yu, Zhaoyuan Zhang, Jishi Wang, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5128.
https://doi.org/10.1182/blood-2018-99-117771
Published: 2018
Journal Articles

The Crucial Role of NR4A1 Dependent Apoptosis Induced By Fenretinide in Acute Myeloid Leukemia

Jie Xiong, Xingyi Kuang, Tingting Lu, Bingqing Cheng, Danna Wei, Xinyao Li, Weili Wang, Zhaoyuan Zhang, Jishi Wang, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5266.
https://doi.org/10.1182/blood-2018-99-117776
Published: 2018
Journal Articles

The Role and Mechanism of Upregulation of HO-1 Expression By Activating of Adenosine-2a Receptor in the Tumor Immune Microenvironment with Diffuse Large B-Cell Lymphoma

Chanjuan Wang, Jishi Wang, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2948.
https://doi.org/10.1182/blood-2018-99-117967
Published: 2018
Journal Articles

Rituximab-Based Regimen As First-Line Treatment in Chinese Patients with Follicular Lymphoma: Three-Year Safety Data from a Prospective, Observational Study

Jianqiu Wu, Yongping Song, Liping Su, Mingzhi Zhang, Wei Li, Yu Hu, MD PhD, Xiaohong Zhang, Yuhuan Gao, Zuoxing Niu, Ru Feng, MD, Wei Wang, Jiewen Peng, Xiaolin Li, Xuenong Ouyang, Changping Wu, Weijing Zhang, Yun Zeng, Zhen Xiao, Yingmin Liang, Yongzhi Zhuang, Jishi Wang, PhD, Zimin Sun, Hai Bai, Tongjian Cui, Jifeng Feng
Journal: Blood
Blood (2017) 130 (Supplement 1): 5167.
https://doi.org/10.1182/blood.V130.Suppl_1.5167.5167
Published: 2017
Journal Articles

The Incidence of HBV Reactivation in Patients Receiving First-Line R-CHOP Chemotherapy: Three-Year Follow-up Results from a Prospective, Observational Study

Jianqiu Wu, Yongping Song, Liping Su, Mingzhi Zhang, Wei Li, Yu Hu, MD PhD, Xiaohong Zhang, Yuhuan Gao, Zuoxing Niu, Ru Feng, MD, Wei Wang, Jiewen Peng, Xuenong Ouyang, Xiaolin Li, Changping Wu, Weijing Zhang, Yun Zeng, Zhen Xiao, Yingmin Liang, Yongzhi Zhuang, Jishi Wang, PhD, Zimin Sun, Hai Bai, Tongjian Cui, Jifeng Feng
Journal: Blood
Blood (2017) 130 (Supplement 1): 5213.
https://doi.org/10.1182/blood.V130.Suppl_1.5213.5213
Published: 2017
Journal Articles

Three-Year Follow-up on Safety and Effectiveness of Rituximab Plus Chemotherapy As First-Line Treatment of Diffuse Large B-Cell Lymphoma

Jifeng Feng, Jianqiu Wu, Yongping Song, Liping Su, Mingzhi Zhang, Wei Li, Yu Hu, MD PhD, Xiaohong Zhang, Yuhuan Gao, Zuoxing Niu, Ru Feng, MD, Wei Wang, Jiewen Peng, Xiaolin Li, Xuenong Ouyang, Changping Wu, Weijing Zhang, Yun Zeng, Zhen Xiao, Yingmin Liang, Yongzhi Zhuang, Jishi Wang, PhD, Zimin Sun, Hai Bai, Tongjian Cui
Journal: Blood
Blood (2017) 130 (Supplement 1): 5208.
https://doi.org/10.1182/blood.V130.Suppl_1.5208.5208
Published: 2017
Journal Articles

Sirolimus Is Effective in Refractory Immune Thrombocytopenia: Results of an Open-Label Prospective Multicenter Trial in China

Lei Gao, Hongju Yan, Sanbin Wang, Fang Liu, Jishi Wang, PhD, Xiaobing Huang, Tonghua Yang, Yanqi Zhang, Shifeng Lou, Huimin Li, Cheng Zhang, MD PhD, Yao Liu, Kong Peiyan, Hong Liu, Li Gao, Xiangui Peng, Yi Su, Yinghao Lu, Feng Li, Defu Zeng, MD, Xi Zhang, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4728.
https://doi.org/10.1182/blood.V130.Suppl_1.4728.4728
Published: 2017